site stats

Cytotronics inc

WebCytotronics is a venture-backed biotechnology company building the next chapter of instruments for multi-parametric, cell-based, high-throughput screening. By designing and developing cell culture plates with embedded high-density electronic systems, our technology enables unique cell-culture parametrics to be measured and manipulated. WebMay 10, 2024 · Congratulations to our Agility Labs member, CytoTronics, on closing $9.25 Million in seed funding, led by Anzu Partners with participation from Milad Alucozai (BoxOne Ventures) and institutional investors, to revolutionize drug discovery and phenotypic screening. Triple Ring is proud to be a part of the journey to provide the facility ...

CytoTronics Launches with $9.25 Million in Seed Funding to ...

WebApr 29, 2024 · CytoTronics leverages CMOS technology to measure and manipulate live cells. CytoTronics advanced CMOS electronics achieves single-cell spatial resolution that greatly enhances the accuracy of the measured cell-biology information and enables optics-free images of growing cells. WebHeadquarters 38 Wareham St, Boston, Massachusetts, 02118, United States (714) 671-9704 CytoTronics Profile and History CytoTronics enables optics-free imaging for drug discovery through its complementary metal-oxide … perils covered by ho-3 and ho-5 https://selbornewoodcraft.com

CytoTronics - Crunchbase Company Profile & Funding

WebApr 28, 2024 · CytoTronics, a biotechnology company building a next-generation complementary metal-oxide-semiconductor (CMOS)-powered drug discovery platform, today announced it has raised $9.25M in initial seed funding, led by Anzu Partners with participation from Milad Alucozai (BoxOne Ventures) and institutional investors. WebCytoTronics is building the next generation of complementary metal-oxide-semiconductor (CMOS) electronics technology for cell measurement and manipulation. CytoTronics, … WebSep 25, 2024 · CytoTronics: Enabling ultrahigh-throughput, multi-parametric, cell-based assays by reinventing traditional microplates via semiconductor technology. Datacule: developing a new solution for digital data storage that changes the economics and environmental cost of securely archiving digital data. perils meaning in chinese

CytoTronics Company Profile Management and Employees List

Category:CytoTronics - BIO CEO & Investor Conference BIO

Tags:Cytotronics inc

Cytotronics inc

CytoTronics - Harvard Innovation Labs

WebApr 28, 2024 · BOSTON– ( BUSINESS WIRE )– CytoTronics, a biotechnology company building a next-generation complementary metal-oxide-semiconductor (CMOS)-powered … WebCytoTronics enables ultra high-throughput, label-free, live-cell and multi- parametric cell-based drug discovery for cell measurement and manipulation. See all Members. Massachusetts Biotechnology Council. 700 Technology Square, 5th Floor Cambridge, MA 02139 617.674.5100. Search for: Search.

Cytotronics inc

Did you know?

WebApr 28, 2024 · CytoTronics raised $9250000 on 2024-04-28 in Seed Round. Anzu Partners Anzu Partners is an investment firm that invests in industrial and life science technology companies.

WebWe would like to show you a description here but the site won’t allow us. WebJun 29, 2024 · $17.5 million ARPA-E grant awarded to Anzu Partners portfolio firm Niron Magnetics, Inc., to drive commercialization of their …

WebCytoTronics contact info: Phone number: (714) 671-9704 Website: www.cytotronics.com What does CytoTronics do? CytoTronics enables optics-free imaging for drug … WebCytoTronics 407 followers on LinkedIn. Optics-free Imaging for Drug Discovery CytoTronics enables optics-free imaging for drug discovery through its complementary metal-oxide-semiconductor (CMOS) electronics platform. Building upon a suite of innovations licensed from Harvard University, CytoTronics’s technology measures and …

WebMar 24, 2024 · The Importance of Anti-Money-Laundering (AML) and Know-Your-Customer (KYC) Mac Funchess • March 16, 2024. If you work for a financial institution of any kind, …

WebApr 28, 2024 · BOSTON, April 28, 2024 -- ( BUSINESS WIRE )-- CytoTronics, a biotechnology company building a next-generation complementary metal-oxide … perils insured basic broad specialWebApr 28, 2024 · BOSTON– ( BUSINESS WIRE )– CytoTronics, a biotechnology company building a next-generation complementary metal-oxide-semiconductor (CMOS)-powered drug discovery platform, today announced it has raised $9.25M in initial seed funding, led by Anzu Partners with participation from Milad Alucozai ( BoxOne Ventures) and institutional … perils in the dark ring the bellsWebCytoTronics , a biotechnology company building a next-generation complementary metal-oxide-semiconductor (CMOS)-powered drug discovery platform, today announced it has … perils in chineseWebOct 27, 2015 · Endonovo Therapeutics Files Patent Application on Cell Therapy Created Using Its Proprietary Cell-Enhancing Cytotronics Platform Therapeutic Represents the First Product to Be Created Using the... perils of indifference american rhetoricWebDescription. Developer of optics-free imaging technology designed for drug discovery. The company's metal-oxide-semiconductor (CMOS) electronics platform measures and … perils of aiWebApr 28, 2024 · CytoTronics will use this seed funding to advance its breakthrough platform that utilizes computer chip technology to conduct a suite of electrical and electrochemical … perils of cosigning a mortgageWebApr 29, 2024 · CytoTronics, a Boston, MA-based biotechnology company, raised $9.25M in Seed funding. The round was led by Anzu Partners with participation from Milad Alucozai (BoxOne Ventures). The company... perils of gene editing